Baidu
map

内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

糖尿病合并高脂血症病证结合诊疗指南

2021-07-19 中国医师协会中西医结合医师分会 世界中医药.

糖尿病

糖尿病合并高脂血症表现为总胆固醇（Total Cholesterol，TC）、三酰甘油（Triacylglycerol，TG）、低密度脂蛋白胆固醇（Low Density Lipoprotein-Ch

中文标题：

糖尿病合并高脂血症病证结合诊疗指南

发布机构：

中国医师协会中西医结合医师分会

发布日期：

2021-07-19

简要介绍：

糖尿病合并高脂血症表现为总胆固醇（Total Cholesterol，TC）、三酰甘油（Triacylglycerol，TG）、低密度脂蛋白胆固醇（Low Density Lipoprotein-Cholesterol，LDL-C）水平升高，高密度脂蛋白胆固醇（High Density Lipoprotein-Cholesterol，HDL-C）下降，是引起糖尿病血管病变的重要危险因素。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=糖尿病合并高脂血症病证结合诊疗指南_倪青.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a0fc51c002139ea7, title=糖尿病合并高脂血症病证结合诊疗指南, enTitle=, guiderFrom=世界中医药., authorId=0, author=, summary=糖尿病合并高脂血症表现为总胆固醇（Total Cholesterol，TC）、三酰甘油（Triacylglycerol，TG）、低密度脂蛋白胆固醇（Low Density Lipoprotein-Ch, cover=https://img.medsci.cn/2021729/1627488335665_2020535.jpg, journalId=0, articlesId=null, associationId=990, associationName=中国医师协会中西医结合医师分会, associationIntro=中国医师协会中西医结合医师分会（Doctor Society of integrative Medicine，Chinese Medical Doctor Association，DSIM/CMDA，以下简称分会）是由中华人民共和国卫生部主管，中华人民共和国民政部批准注册，隶属中国医师协会的二级学会组织，于2007年11月9日至10日在北京正式成立。享誉国内外的著名中西医结合专家陈可冀院士担任会长，以中国中医科学院西苑医院为依托单位，由来自全国26省市地区及香港特别行政区的代表共128人组成了第一届委员会，充分体现了广泛的学术和区域代表性。由具备长期从事中西医结合工作经历的执业医师、管理人员及团体组成的全国性、行业性、非盈利性的群众组织，分会本着中国医师协会&ldquo;服务、协调、自律、维权、监督、管理&rdquo;宗旨，致力于加强中西医结合医师队伍的建设和管理，弘扬以人为本、救死扶伤的人道主义，维护我国中西医结合医师的正当义务权益，发挥中西医结合的特色与互补优势，促进中西医学术交流，提高临床综合服务能力，弘杨传统中医药学术的继承和发展，为我国人民健康和社会主义建设服务。, copyright=0, guiderPublishedTime=Mon Jul 19 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">糖尿病合并高脂血症表现为总胆固醇（Total Cholesterol，TC）、三酰甘油（Triacylglycerol，TG）、低密度脂蛋白胆固醇（Low Density Lipoprotein-Cholesterol，LDL-C）水平升高，高密度脂蛋白胆固醇（High Density Lipoprotein-Cholesterol，HDL-C）下降，是引起糖尿病血管病变的重要危险因素。&nbsp;</span></p>, tagList=[TagDto(tagId=216, tagName=糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=15116, appHits=440, showAppHits=0, pcHits=1141, showPcHits=14674, likes=3, shares=32, comments=22, approvalStatus=1, publishedTime=Sat Jul 31 22:52:04 CST 2021, publishedTimeString=2021-07-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 29 00:05:44 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 14:30:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=糖尿病合并高脂血症病证结合诊疗指南_倪青.pdf)])
糖尿病合并高脂血症病证结合诊疗指南_倪青.pdf
下载请点击：
评论区 (20)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1219018, encodeId=a76a12190186c, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/df82e0cde01a4cf691cd117ea1d92f92/e8f5384bf5a046e39e049573730dd6ec.jpg, createdBy=4b6d3851900, createdName=pqssy, createdTime=Thu May 12 11:44:06 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214472, encodeId=43b612144e24f, content=<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>合并<a href='/topic/show?id=fc78102625d7' target=_blank style='color:#2F92EE;'>#高脂血症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病), TopicDto(id=102625, encryptionId=fc78102625d7, topicName=高脂血症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 13:24:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190722, encodeId=b90f1190e22d1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Mon Feb 07 13:41:47 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182713, encodeId=c9421182e134a, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Mon Jan 10 07:13:14 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085491, encodeId=ba6d10854915c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=210b4868969, createdName=278103059, createdTime=Wed Dec 29 16:23:00 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-05-12 pqssy

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1219018, encodeId=a76a12190186c, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/df82e0cde01a4cf691cd117ea1d92f92/e8f5384bf5a046e39e049573730dd6ec.jpg, createdBy=4b6d3851900, createdName=pqssy, createdTime=Thu May 12 11:44:06 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214472, encodeId=43b612144e24f, content=<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>合并<a href='/topic/show?id=fc78102625d7' target=_blank style='color:#2F92EE;'>#高脂血症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病), TopicDto(id=102625, encryptionId=fc78102625d7, topicName=高脂血症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 13:24:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190722, encodeId=b90f1190e22d1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Mon Feb 07 13:41:47 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182713, encodeId=c9421182e134a, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Mon Jan 10 07:13:14 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085491, encodeId=ba6d10854915c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=210b4868969, createdName=278103059, createdTime=Wed Dec 29 16:23:00 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-04-26 病毒猎手

    #糖尿病#合并#高脂血症#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1219018, encodeId=a76a12190186c, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/df82e0cde01a4cf691cd117ea1d92f92/e8f5384bf5a046e39e049573730dd6ec.jpg, createdBy=4b6d3851900, createdName=pqssy, createdTime=Thu May 12 11:44:06 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214472, encodeId=43b612144e24f, content=<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>合并<a href='/topic/show?id=fc78102625d7' target=_blank style='color:#2F92EE;'>#高脂血症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病), TopicDto(id=102625, encryptionId=fc78102625d7, topicName=高脂血症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 13:24:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190722, encodeId=b90f1190e22d1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Mon Feb 07 13:41:47 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182713, encodeId=c9421182e134a, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Mon Jan 10 07:13:14 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085491, encodeId=ba6d10854915c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=210b4868969, createdName=278103059, createdTime=Wed Dec 29 16:23:00 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-02-07 1e129e46m43(暂无匿称)

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1219018, encodeId=a76a12190186c, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/df82e0cde01a4cf691cd117ea1d92f92/e8f5384bf5a046e39e049573730dd6ec.jpg, createdBy=4b6d3851900, createdName=pqssy, createdTime=Thu May 12 11:44:06 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214472, encodeId=43b612144e24f, content=<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>合并<a href='/topic/show?id=fc78102625d7' target=_blank style='color:#2F92EE;'>#高脂血症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病), TopicDto(id=102625, encryptionId=fc78102625d7, topicName=高脂血症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 13:24:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190722, encodeId=b90f1190e22d1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Mon Feb 07 13:41:47 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182713, encodeId=c9421182e134a, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Mon Jan 10 07:13:14 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085491, encodeId=ba6d10854915c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=210b4868969, createdName=278103059, createdTime=Wed Dec 29 16:23:00 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-01-10 ms7000000167247375

    学习#学习#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1219018, encodeId=a76a12190186c, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/df82e0cde01a4cf691cd117ea1d92f92/e8f5384bf5a046e39e049573730dd6ec.jpg, createdBy=4b6d3851900, createdName=pqssy, createdTime=Thu May 12 11:44:06 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214472, encodeId=43b612144e24f, content=<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>合并<a href='/topic/show?id=fc78102625d7' target=_blank style='color:#2F92EE;'>#高脂血症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76652, encryptionId=4f77e665253, topicName=糖尿病), TopicDto(id=102625, encryptionId=fc78102625d7, topicName=高脂血症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 13:24:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190722, encodeId=b90f1190e22d1, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Mon Feb 07 13:41:47 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182713, encodeId=c9421182e134a, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Mon Jan 10 07:13:14 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085491, encodeId=ba6d10854915c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=210b4868969, createdName=278103059, createdTime=Wed Dec 29 16:23:00 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 278103059

    学习了

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2021 老年2型糖尿病管理专家共识——糖尿病和衰弱

国外内分泌相关专家小组（统称） · 2021-05-12

中国养老机构居民血糖标准管理临床专家共识（2021版）

中国老年协会内分泌代谢病学组 · 2021-07-07

基层糖尿病微血管病变筛查与防治专家共识（2021年版）

中国微循环学会(CMS,Chinese Society of Microcirculation) 糖尿病与微循环专业委员会 · 2021-06-17

2021 AIOM_AMD_SIE_SIF多学科共识意见：新发糖尿病胰腺癌的早期预测

意大利肿瘤医学协会(AIOM,Italian Association of Medical Oncology) · 2021-05-18

互联网医院糖尿病线上管理中国专家共识

中国老年保健协会 · 2021-05-19

SGLT-2抑制剂和GLP-1激动剂对成人2型糖尿病临床实践指南

暂未更新 · 2021-05-13

拓展阅读

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA（POA）糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 （2010年）

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01

Baidu
map
Baidu
map
Baidu
map